Immune markers for monitoring the progression of autoimmune disease.
The incidence of immune-mediated diseases is increasing worldwide. Reliable immune markers for monitoring disease progression and also the effect of therapeutic interventions are urgently needed in order to investigate preventive or therapeutic measures effectively. At a recent workshop held on 5 December 1998 in Copenhagen, the state of research on surrogate markers in Type 1 diabetes was discussed and compared with the experience in multiple sclerosis, inflammatory bowel disease and transplantation.
Schloot
N C
NC
Diabetes Research Institute, Düsseldorf, Germany. n.schloot@t-online.de
Pozzilli
P
P
Mandrup-Poulsen
T
T
D001327:Autoimmune Diseases / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology*; D015415:Biomarkers / Q000032:analysis*; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology*; D018450:Disease Progression; D014943:Global Health; D006801:Humans; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000276:immunology / Q000503:physiopathology; D009103:Multiple Sclerosis / Q000276:immunology / Q000503:physiopathology; D014181:Transplantation Immunology
D015415:Biomarkers